Let's spread the word about Immunotherapy! Click to share this page with your community.

CIM21 Twitter Takeover with @InflammatoryDC

On Friday, June 25, 2021, Kamir J. Hiam-Galvez, Ph.D., a CRI Postdoctoral Fellow at Stanford University, will take over the Cancer Research Institute Twitter account (@CancerResearch) and share a day in the life of a scientist.  

Dr. Hiam-Galvez, who regularly tweets from @InflammatoryDC, aims to improve our knowledge of the importance of CD4+ “helper” T cells in killing cancer cells using sophisticated new technologies.  

Follow CRI Fellow Dr. Hiam-Galvez on Twitter and learn about the single-cell sequencing technology used in a lab. Visit our Twitter account @CancerResearch or follow along with the hashtag #CIM21.  


Photo by Joshua Hoehne on Unsplash

*Immunotherapy results may vary from patient to patient.